These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 24002698)
1. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698 [TBL] [Abstract][Full Text] [Related]
2. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940 [TBL] [Abstract][Full Text] [Related]
3. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing. Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527 [TBL] [Abstract][Full Text] [Related]
4. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry. Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121 [TBL] [Abstract][Full Text] [Related]
5. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens. Xu H; Sun W; Zhang G; Cheng Y J BUON; 2015; 20(1):142-5. PubMed ID: 25778309 [TBL] [Abstract][Full Text] [Related]
6. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. Sequist LV; Martins RG; Spigel D; Grunberg SM; Spira A; Jänne PA; Joshi VA; McCollum D; Evans TL; Muzikansky A; Kuhlmann GL; Han M; Goldberg JS; Settleman J; Iafrate AJ; Engelman JA; Haber DA; Johnson BE; Lynch TJ J Clin Oncol; 2008 May; 26(15):2442-9. PubMed ID: 18458038 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of an Australian testing programme for epidermal growth factor receptor mutations in non-small cell lung cancer. Peters MJ; Bowden JJ; Carpenter P; Lewis J; Solomon B Intern Med J; 2014 Jun; 44(6):575-80. PubMed ID: 24720523 [TBL] [Abstract][Full Text] [Related]
9. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer. Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions. Hung MS; Lin CK; Leu SW; Wu MY; Tsai YH; Yang CT Chang Gung Med J; 2006; 29(4):373-9. PubMed ID: 17051834 [TBL] [Abstract][Full Text] [Related]
11. EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. Malapelle U; Bellevicine C; De Luca C; Salatiello M; De Stefano A; Rocco D; de Rosa N; Vitiello F; Russo S; Pepe F; Iaccarino A; Micheli P; Illiano A; Carlomagno C; Piantedosi FV; Troncone G Cancer Cytopathol; 2013 Oct; 121(10):552-60. PubMed ID: 23780873 [TBL] [Abstract][Full Text] [Related]
12. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer. He C; Zheng L; Xu Y; Liu M; Li Y; Xu J Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554 [TBL] [Abstract][Full Text] [Related]
13. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients. Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ Respiration; 2013; 85(2):119-25. PubMed ID: 22797485 [TBL] [Abstract][Full Text] [Related]
15. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations. Won YW; Han JY; Lee GK; Park SY; Lim KY; Yoon KA; Yun T; Kim HT; Lee JS J Clin Pathol; 2011 Nov; 64(11):947-52. PubMed ID: 21725039 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769 [TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. Han SW; Kim TY; Hwang PG; Jeong S; Kim J; Choi IS; Oh DY; Kim JH; Kim DW; Chung DH; Im SA; Kim YT; Lee JS; Heo DS; Bang YJ; Kim NK J Clin Oncol; 2005 Apr; 23(11):2493-501. PubMed ID: 15710947 [TBL] [Abstract][Full Text] [Related]
19. Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer. Ikeda T; Nakamura Y; Yamaguchi H; Tomonaga N; Doi S; Nakatomi K; Iida T; Motoshima K; Mizoguchi K; Nagayasu T; Tsukamoto K; Kohno S Clin Lung Cancer; 2012 Sep; 13(5):369-74. PubMed ID: 22410386 [TBL] [Abstract][Full Text] [Related]
20. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer. Mu XL; Li LY; Zhang XT; Wang MZ; Feng RE; Cui QC; Zhou HS; Guo BQ Clin Cancer Res; 2005 Jun; 11(12):4289-94. PubMed ID: 15958609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]